Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions: A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis.

Date publication

mars 2018

Journal

Stroke

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Gautheron V, Xie Y, Tisserand M, Raoult H, Soize S, Naggara O, Bourcier R, Richard S, Guillemin F, Bracard S, Oppenheim C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29382803

Résumé

Stroke patients with large diffusion-weighted imaging (DWI) volumes are often excluded from reperfusion because of reckoned futility. In those with DWI >70 mL, included in the THRACE trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke), we report the associations between baseline parameters and outcome.

Mots clés

Adolescent, Adult, Aged, Aged, 80 and over, Diffusion Magnetic Resonance Imaging, Female, Humans, Male, Middle Aged, Stroke, diagnostic imaging, Thrombectomy, methods, Tissue Plasminogen Activator, administration & dosage

Référence

Stroke. 2018 03;49(3):750-753